Poisoning
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Poisoning is an emerging landscape with 20 programs across 10 companies. The most active players are Iperboreal Pharma Srl, Boehringer Ingelheim, Azurity Pharmaceuticals. 5 therapies are approved with 6 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Iperboreal Pharma Srl
1 program
Boehringer Ingelheim
1 program
Azurity Pharmaceuticals
1 program
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
1 program
Cloudbreak Therapeutics, LLC
1 program
Fresenius Kabi Oncology Ltd.
3 programs
Pipeline
Programs by Phase
Analysis
Modality Breakdown
96%
Small molecule
23 of 24 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 24 classified programs, each share of the total. Modality classified for 100% of 25 pipeline programs.
Analysis
Trial Status
25
clinical trials
Clinical Trials
Trial Activity
25 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)